盈利预期调整
搜索文档
Reservoir Media, Inc. (RSVR) Q2 Earnings Lag Estimates
ZACKS· 2025-11-04 22:55
Reservoir Media, Inc. (RSVR) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -40.00%. A quarter ago, it was expected that this company would post a loss of $0.01 per share when it actually produced a loss of $0.01, delivering no surprise.Over the last four quarters, the company has ...
Integral Ad Science (IAS) Q3 Earnings Miss Estimates
ZACKS· 2025-11-04 22:50
Integral Ad Science (IAS) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.1 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -22.22%. A quarter ago, it was expected that this digital advertising verification company would post earnings of $0.04 per share when it actually produced earnings of $0.07, delivering a surprise of +75%.Over th ...
Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates
ZACKS· 2025-11-04 22:41
Neuronetics (STIM) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -18.18%. A quarter ago, it was expected that this medical device company focused on psychiatric disorders would post a loss of $0.08 per share when it actually produced a loss of $0.15, delivering a surprise of -87.5%.Over t ...
Verastem (VSTM) Reports Q3 Loss, Tops Revenue Estimates
ZACKS· 2025-11-04 22:41
季度业绩表现 - 季度每股亏损为1.35美元,远高于市场预期的每股亏损0.51美元,也高于去年同期每股亏损0.6美元 [1] - 本季度盈利意外为-164.71%,而上一季度盈利意外为+54.12%,当时实际每股亏损0.39美元,优于预期的每股亏损0.85美元 [1] - 在过去四个季度中,公司仅有一次超过每股收益预期 [2] - 季度收入为1124万美元,大幅超过市场预期82.80%,去年同期收入为零 [2] 股价表现与市场展望 - 今年以来公司股价已上涨约91.5%,同期标普500指数涨幅为16.5% [3] - 公司当前Zacks评级为第2级(买入),预计短期内股价表现将优于市场 [6] - 业绩公布前,盈利预期修正趋势向好 [6] 未来业绩预期 - 对下一季度的市场普遍预期为每股亏损0.42美元,收入2207万美元 [7] - 对本财年的市场普遍预期为每股亏损2.44美元,收入1875万美元 [7] 行业比较与同业公司 - 公司所属的医疗-生物医学和遗传学行业,在Zacks行业排名中位列前39% [8] - 同业公司Arvinas Inc (ARVN) 预计在即将公布的报告中季度每股亏损为0.75美元,同比变化-10.3% [9] - 过去30天内,Arvinas的季度每股收益预期已上调7.1%至当前水平 [9] - Arvinas预计季度收入为2698万美元,较去年同期下降73.7% [10]
Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Miss Estimates
ZACKS· 2025-11-04 22:41
Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.87 per share, missing the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.79 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -5.43%. A quarter ago, it was expected that this company would post earnings of $0.78 per share when it actually produced earnings of $0.68, delivering a surprise of -12.82%.Over the last four qu ...
Amicus Therapeutics (FOLD) Beats Q3 Earnings and Revenue Estimates
ZACKS· 2025-11-04 22:37
Amicus Therapeutics (FOLD) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.1 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +41.67%. A quarter ago, it was expected that this pharmaceutical company would post earnings of $0.02 per share when it actually produced earnings of $0.01, delivering a surprise of -50%.Over the last four quart ...
Xometry (XMTR) Q3 Earnings Match Estimates
ZACKS· 2025-11-04 22:37
Xometry (XMTR) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this marketplace for on-demand manufacturing would post earnings of $0.05 per share when it actually produced earnings of $0.09, delivering a surprise of +80%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Xomet ...
Anywhere Real Estate (HOUS) Reports Break-Even Earnings for Q3
ZACKS· 2025-11-04 22:16
Anywhere Real Estate (HOUS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.18. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -100.00%. A quarter ago, it was expected that this real estate brokerage operator would post earnings of $0.34 per share when it actually produced earnings of $0.32, delivering a surprise of -5.88%.Over the last four quarter ...
CDW (CDW) Beats Q3 Earnings and Revenue Estimates
ZACKS· 2025-11-04 22:11
CDW (CDW) came out with quarterly earnings of $2.71 per share, beating the Zacks Consensus Estimate of $2.62 per share. This compares to earnings of $2.63 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.44%. A quarter ago, it was expected that this information technology company would post earnings of $2.49 per share when it actually produced earnings of $2.6, delivering a surprise of +4.42%.Over the last four quarters, the ...
Kymera Therapeutics, Inc. (KYMR) Reports Q3 Loss, Misses Revenue Estimates
ZACKS· 2025-11-04 22:11
Kymera Therapeutics, Inc. (KYMR) came out with a quarterly loss of $0.9 per share versus the Zacks Consensus Estimate of a loss of $0.71. This compares to a loss of $0.82 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -26.76%. A quarter ago, it was expected that this company would post a loss of $0.83 per share when it actually produced a loss of $0.95, delivering a surprise of -14.46%.Over the last four quarters, the company ...